Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
18 mars 2024 07h05 HE
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey
08 janv. 2024 18h01 HE
|
Er-Kim
Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey
Immunoassay Market Set to Surge at 5.0% CAGR, to Reach USD 48.7 billion by 2031 | Transparency Market Research, Inc.
04 janv. 2024 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The immunoassay market was valued at US$ 31.5 billion in 2022. A CAGR of 5.0% is expected...
Living with diabetes for decades
05 déc. 2023 08h00 HE
|
Norton Healthcare
LOUISVILLE, Ky., Dec. 05, 2023 (GLOBE NEWSWIRE) -- In her new book, “Diabetes and Me: Living a Healthy and Empowered Life in the Face of Diabetes” (ISBN-13 9781633310803, Nov. 14, 2023),...
Home Infusion Therapy Market Size to Hit 8.6% CAGR with Infusion Pumps Segment Driving Growth During 2022–2028 | The Insight Partners
24 oct. 2023 14h46 HE
|
The Insight Partners
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed...
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Medicine Program
16 oct. 2023 11h00 HE
|
Castle Connolly Private Health Partners
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Program
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
19 sept. 2023 09h30 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Pharmaceutical Intermediates Market Predicted to Reach USD 53.4 billion by 2031, Expanding at a CAGR of 6% Says, Transparency Market Research
29 août 2023 04h53 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global pharmaceutical intermediates market is projected to flourish at a CAGR of 6%...
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
20 juin 2023 08h30 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 20, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or testosterone deficiency, announced today...
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
09 juin 2023 10h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...